Back to Search
JUAN CORTES, DO
DO
Family Medicine Physician
NPI: 1760432181Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
20A8012(CA)
Research & Publications (20)
Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos.
PMID 19401322·Hum Reprod·2009
7-preclinical
T-Cell acute lymphoblastic leukemia with a "pinch" of BCR-ABL1.
PMID 19294558·Leuk Lymphoma·2009
8-other
Reproductive medicine meets human embryonic stem cell (hESC) research: the need to adjust the regulatory framework to actual expectations and potential detrimental consequences of hESC research.
PMID 18692797·Fertil Steril·2009
8-other
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.
PMID 19340529·Int J Hematol·2009
8-other
Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia.
PMID 19404318·Leukemia·2009
6-review
Trends in healthcare utilization for diarrhea and rotavirus disease in privately insured US children <5 years of age, 2001-2006.
PMID 19590460·Pediatr Infect Dis J·2009
8-other
Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001.
PMID 19484334·Int J Hematol·2009
3-trial
Whole-blastocyst culture followed by laser drilling technology enhances the efficiency of inner cell mass isolation and embryonic stem cell derivation from good- and poor-quality mouse embryos: new insights for derivation of human embryonic stem cell lines.
PMID 18447641·Stem Cells Dev·2008
7-preclinical
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.
PMID 18754032·Leukemia·2008
3-trial
Beyond dose escalation: clinical options for relapse or resistance in chronic myelogenous leukemia.
PMID 18397678·J Natl Compr Canc Netw·2008
6-review
Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors.
PMID 17785585·Blood·2007
8-other
Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3.
PMID 17785825·J Immunol·2007
7-preclinical
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure.
PMID 17849425·Cancer·2007
3-trial
Phase 1 study of lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib.
PMID 17623836·Cancer·2007
3-trial
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.
PMID 17185463·Blood·2007
3-trial
Spanish stem cell bank interviews examine the interest of couples in donating surplus human IVF embryos for stem cell research.
PMID 18371329·Cell Stem Cell·2007
8-other
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal.
PMID 16463391·Cancer·2006
8-other
Effects of fast presynaptic noise in attractor neural networks.
PMID 16483410·Neural Comput·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10350 COMMERCE CENTER DR, SUITE 200
RANCHO CUCAMONGA, CA 91730 - Phone
- (800) 579-7202
Quick Facts
- NPI
- 1760432181
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile